Literature DB >> 9441909

Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs.

R D Bernstein1, X Zhang, G Zhao, P Forfia, J Tuzman, F Ochoa, M Ochoa, T Vogel, T H Hintze.   

Abstract

The goal of this study was to understand the mechanisms behind the changes in plasma NOx during heart failure. Heart failure is associated with an increase in plasma nitrate levels, and yet most experimental evidence demonstrates a reduction in endothelial nitric oxide production during heart failure. Dogs were chronically instrumented for measurement of systemic hemodynamics and left ventricular (LV) dimensions. Hearts were paced at 210 bpm for 3 weeks (n = 14) and then 240 bpm for 1 week (n = 7). Hemodynamics, arterial blood gases, plasma NOx, and creatinine levels were monitored weekly. Heart failure was evidenced by cachexia, ascites, and hemodynamic alterations. Resting heart rate rose (94 +/- 6 to 135 +/- 9 bpm), and LV dP/dt fell (2810 +/- 82 to 1471 +/- 99 mm Hg/s), while LV end diastolic pressure quadrupled (5.8 +/- 0.7 to 25 +/- 0.8 mm Hg), and diastolic wall stress quadrupled (11 +/- 1.3 to 43 +/- 6.0 g/cm2, all P < 0.05). These changes occurred during a doubling in plasma NOx (5.5 +/- 1.5 to 10 +/- 1.6 microM, P < 0.05). There were no changes in plasma NOx through 3 weeks of pacing. Plasma creatinine levels increased 450% (from 0.27 +/- 0.32 to 1.21 +/- 0.63 mg%). Stimulated nitrite production by agonists in sieved coronary microvessels was unchanged after 3 weeks of pacing but was reduced after heart failure. Plasma NOx did not correlate with LV dP/dt or systolic wall stress but correlated directly with LV EDP or diastolic wall stress and inversely with cardiac work. Plasma NOx rose in direct relation to plasma creatinine levels (Y = 4.8X + 2.8, r2 = 0.84), suggesting that the rise in plasma NOx during heart failure is due to decreased renal function not increased NO production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441909     DOI: 10.1006/niox.1997.0150

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  4 in total

1.  Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.

Authors:  W H Wilson Tang; Kevin Shrestha; Zeneng Wang; Richard W Troughton; Allan L Klein; Stanley L Hazen
Journal:  J Card Fail       Date:  2013-02       Impact factor: 5.712

2.  Myocyte repolarization modulates myocardial function in aging dogs.

Authors:  Andrea Sorrentino; Sergio Signore; Khaled Qanud; Giulia Borghetti; Marianna Meo; Antonio Cannata; Yu Zhou; Ewa Wybieralska; Marco Luciani; Ramaswamy Kannappan; Eric Zhang; Alex Matsuda; Andrew Webster; Maria Cimini; Elizabeth Kertowidjojo; David A D'Alessandro; Oriyanhan Wunimenghe; Robert E Michler; Christopher Royer; Polina Goichberg; Annarosa Leri; Edward G Barrett; Piero Anversa; Thomas H Hintze; Marcello Rota
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-22       Impact factor: 4.733

Review 3.  The NO/ONOO-cycle as the central cause of heart failure.

Authors:  Martin L Pall
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

4.  Low-frequency blood flow oscillations in congestive heart failure and after beta1-blockade treatment.

Authors:  A Bernjak; P B M Clarkson; P V E McClintock; A Stefanovska
Journal:  Microvasc Res       Date:  2008-08-05       Impact factor: 3.514

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.